Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
34.92 CHF | -.--% |
|
-19.92% | -6.81% |
05-29 | UK’s Competition Regulator Closes Cochlear-Demant Deal | MT |
05-21 | Denmark's Demant Completes Sale of Cochlear Implants Business | MT |
Sales 2024 * | 23.23B 3.34B 2.98B 4.55B | Sales 2025 * | 24.97B 3.59B 3.21B 4.89B | Capitalization | 67.14B 9.64B 8.63B 13.16B |
---|---|---|---|---|---|
Net income 2024 * | 3.04B 436M 391M 596M | Net income 2025 * | 3.52B 505M 452M 690M | EV / Sales 2024 * | 3.47 x |
Net Debt 2024 * | 13.57B 1.95B 1.74B 2.66B | Net Debt 2025 * | 13.25B 1.9B 1.7B 2.6B | EV / Sales 2025 * | 3.22 x |
P/E ratio 2024 * |
22
x | P/E ratio 2025 * |
18.6
x | Employees | 21,623 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 39.27% |
Latest transcript on Demant A/S
Current month | -6.81% | ||
Current year | -6.81% |
![Extreme 34.92400000](/images/extremecours_fleche.png)
![Extreme 34.92400000](/images/extremecours_fleche.png)
![Extreme 34.92400000](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
René Schneider
DFI | Director of Finance/CFO | 51 | 15-08-31 |
Niels Jacobsen
BRD | Director/Board Member | 66 | 91-12-31 |
Peter Pudselykke
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 58 | 07-12-31 | |
Niels Jacobsen
BRD | Director/Board Member | 66 | 91-12-31 |
Director/Board Member | 57 | 20-12-31 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.32% | 19.5B | |
+9.67% | 14.46B | |
-23.62% | 1.9B | |
+2.37% | 1.72B | |
+0.53% | 1.24B | |
+2.56% | 525M | |
0.00% | 372M | |
+99.76% | 231M | |
+17.85% | 99.2M |
- Stock Market
- Equities
- DEMANT Stock
- WDH1 Stock